SP1 and cancer: In conclusion, JUN, NFKB1 and SP1 may jointly maintain the characteristics of cancer stem cells by regulating the stemness maintenance and telomerase activity of cancer stem cells, thus influencing the progression, treatment resistance and recurrence of BC.